Literature DB >> 17661352

Histone deacetylases in control of skeletogenesis.

Jennifer J Westendorf1.   

Abstract

Skeletogenesis occurs continuously during the lifespan of vertebrate organisms. In development, the skeleton is patterned and modeled until each bone achieves its optimal shape and full size. During adults, the skeleton is remodeled to maintain strength and release calcium. The bone-resorbing and bone-forming activities of osteoclasts and osteoblasts, respectively, are tightly coupled to maintain optimal skeletal health; however, during aging and disease, these cells can become uncoupled, adversely affecting skeletal health and strength. Histone deacetylases have emerged as important regulators of endochondral bone formation, osteoblast maturation and osteoclast survival. Histone deacetylases are inhibited by small molecules that are approved and/or in clinical trials as cancer therapeutic drugs or anti-epileptic agents. In this article, the roles of histone deacetylases and effects of histone deacetylase inhibitors on bone and cartilage cells are reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661352     DOI: 10.1002/jcb.21486

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  20 in total

1.  Genetic and maternal effects on valproic acid teratogenesis in C57BL/6J and DBA/2J mice.

Authors:  Chris Downing; Jami Biers; Colin Larson; Alexi Kimball; Hali Wright; Takamasa Ishii; David Gilliam; Thomas Johnson
Journal:  Toxicol Sci       Date:  2010-05-10       Impact factor: 4.849

Review 2.  Hdac-mediated control of endochondral and intramembranous ossification.

Authors:  Elizabeth W Bradley; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

3.  Essential role of ARID2 protein-containing SWI/SNF complex in tissue-specific gene expression.

Authors:  Fuhua Xu; Stephen Flowers; Elizabeth Moran
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

Review 4.  Transcriptional networks controlling chondrocyte proliferation and differentiation during endochondral ossification.

Authors:  Manuela Wuelling; Andrea Vortkamp
Journal:  Pediatr Nephrol       Date:  2009-12-01       Impact factor: 3.714

Review 5.  Epigenetic histone modifications and master regulators as determinants of context dependent nuclear receptor activity in bone cells.

Authors:  J Wesley Pike; Mark B Meyer; Hillary C St John; Nancy A Benkusky
Journal:  Bone       Date:  2015-03-27       Impact factor: 4.398

Review 6.  Epigenetic regulation of bone cells.

Authors:  Kyung Hyun Park-Min
Journal:  Connect Tissue Res       Date:  2016-04-14       Impact factor: 3.417

7.  Parathyroid hormone regulates histone deacetylase (HDAC) 4 through protein kinase A-mediated phosphorylation and dephosphorylation in osteoblastic cells.

Authors:  Emi Shimizu; Teruyo Nakatani; Zhiming He; Nicola C Partridge
Journal:  J Biol Chem       Date:  2014-06-05       Impact factor: 5.157

Review 8.  Metastatic bone disease: role of transcription factors and future targets.

Authors:  Jitesh Pratap; Jane B Lian; Gary S Stein
Journal:  Bone       Date:  2010-06-01       Impact factor: 4.398

9.  Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat.

Authors:  David F Razidlo; Tiffany J Whitney; Michelle E Casper; Meghan E McGee-Lawrence; Bridget A Stensgard; Xiaodong Li; Frank J Secreto; Sarah K Knutson; Scott W Hiebert; Jennifer J Westendorf
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

10.  HDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repression.

Authors:  Emi Shimizu; Nagarajan Selvamurugan; Jennifer J Westendorf; Eric N Olson; Nicola C Partridge
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.